Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013
Seeking Alpha
Friday, November 30, 2012 - 12:17pm
tags:
Aeterna Zentaris, Celsion, OncoSec Medical
Should Congress Probe FDA Over Generic Lipitor?
Pharmalot
Friday, November 30, 2012 - 12:14pm
tags:
FDA, generics, Lipitor, Ranbaxy
3 Top Biopharma Stocks of 2012
Motley Fool
Friday, November 30, 2012 - 12:13pm
tags:
Arena Pharmaceuticals, Celsion, Sarepta Therapeutics
Wall Street Loves Galena Biopharma. Should You?
Motley Fool
Friday, November 30, 2012 - 12:12pm
tags:
Galena Biopharma
Athersys Should Gain At Least 50%
Seeking Alpha
Friday, November 30, 2012 - 12:12pm
tags:
Athersys, stem cells, MultiStem
[video] The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo
TheStreet.com
Friday, November 30, 2012 - 12:11pm
tags:
Biomarin, Sangamo BioSciences, Ligand
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Friday, November 30, 2012 - 12:10pm
tags:
hepatitis C, Achillion, Gilead, Idenix, Merck, Medivir, Vertex Pharmaceuticals
FDA Panel Turns Thumbs Down on Vibativ
Med Page Today
Friday, November 30, 2012 - 10:40am
tags:
FDA, advisory panels, Vibativ, hospital-acquired pneumonia
Teva Pharma sees 2013 revenue of about $20 bln
Marketwatch
Friday, November 30, 2012 - 10:37am
tags:
Teva
Who Wins With Generic Lipitor Recall?
Motley Fool
Friday, November 30, 2012 - 10:36am
tags:
recalls, generics, Lipitor, Pfizer, Ranbaxy, Watson Pharmaceuticals, Teva, Mylan
Hot flashes may return after ending Lexapro antidepressant: study
Reuters
Friday, November 30, 2012 - 10:34am
tags:
Lexapro, hot flashes, antidepressants, Forest Labs
J&J CEO Gorsky elected chairman, replacing Weldon
Reuters
Friday, November 30, 2012 - 9:41am
tags:
JNJ, Pharma CEOs, William Weldon, Alex Gorsky
FDA Rejection. EU Withdrawal. Set and Match?
Motley Fool
Friday, November 30, 2012 - 9:39am
tags:
FDA, Europe, ridaforolimus, Ariad Pharma, Merck
Exelixis Wins First Approval of Cancer Drug
Minyanville
Friday, November 30, 2012 - 9:37am
tags:
medullary thyroid cancer, Exelixis, Cometriq
Lpath's Q3 Filing Shines The Way For A Catalyst Filled 2013
Seeking Alpha
Friday, November 30, 2012 - 9:34am
tags:
Lpath, Pfizer, iSONEP
InterMune Gearing Up For Another Round With The FDA
Yahoo/Reuters
Thursday, November 29, 2012 - 12:03pm
tags:
InterMune, FDA, IPF, idiopathic pulmonary fibrosis, pirfenidone
Arena Opening New Doors
Seeking Alpha
Thursday, November 29, 2012 - 12:01pm
tags:
Arena Pharmaceuticals, IIdong Pharmaceuticals, Temanogrel, South Korea
Orphan Drug Status Potentially Huge For DARA Bio
Seeking Alpha
Thursday, November 29, 2012 - 11:58am
tags:
DARA Biosciences, orphan drugs, KRN5500, chronic chemotherapy-induced peripheral neuropathy
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Motley Fool
Thursday, November 29, 2012 - 11:05am
tags:
Revlimid, Celgene, Vidaza, Abraxane, apremilast, pomalidomide
J&J says won't enforce AIDS drug patent in Africa
Reuters
Thursday, November 29, 2012 - 11:04am
tags:
AIDS, JNJ, Africa, patents, Prezista

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.